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Abstract Objectives To investigate the expression of histamine H1 receptors (H1R) in the vestibular nucleus of
brainstem in rats and the role of H1R in motion sickness（MS）. Methods A total of 24 healthy Sprague-Dawley
rats were divided randomly into four groups（n=6 each）which determined if the animals would receive induction of
MS or drug（promethazine）treatment: MS（-）/Drug（-）; MS(+)/Drug（-）; MS（-）/Drug（+ at 0.25 mg）; and MS（+）/
Drug（+）. MS was induced by complex motion stimulation and the conditioned taste aversion was used as a behavioral
indicator of MS. The volume of 0.15% sodium saccharin solution（SS）intake within 45 minutes after motion stimula⁃
tion was measured. H1R in the vestibular nucleus was examined by immunofluorescence staining. The expression of
H1R protein in brainstem tissue at vestibular nucleus level was detected by western blot. Results The mean SS in⁃
take volume in the MS（+）/Drug（-）group（8.8 ml）was significantly less than that of the MS（-）/Drug（-）group
（15.1 ml）（P < 0.01). The mean SS intake volume of the MS（-）/Drug（+）group（14.8 ml）was similar to that of the
MS（-）/Drug（-）group. The mean SS intake volume（9.6 ml）of the MS（+）/Drug（+）group was more than that of the
MS（+）/Drug（-）group（P < 0.01）, but less than that of the MS（-）/Drug（-）group or MS（-）/Drug（+）group（P <
0.01）. Immunofluorescence staining showed positive expression of H1R in the vestibular nucleus of brainstem and
the expression was enhanced by motion stimulation. Western blot analysis showed that H1R protein expressed in the
brainstem tissue at vestibular nucleus level and the expression also increased significantly after motion stimulation.
The MS-induced increase of H1R was not affected significantly by promethazine. Conclusions H1Rs exist in the
vestibular nucleus in rats and H1R expression is up-regulated by motion stimulation, but not affected by prometha⁃
zine. The findings indicate that the histaminergic system is involved in MS. Promethazine, as an H1R blocker, may
play its anti-MS role by competing the binding site on H1Rs with histamine rather than inhibiting H1R expression.
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Introduction
Motion sickness（MS）induced by various motion stimu⁃
lation is known by many names, for example, car sick⁃
ness, sea sickness, air sickness, and space sickness.
The incidence of MS varies, depending on the magni⁃
tude of the stimulation and the individual susceptibility
to the stimulation. MS is experienced by 60%-80% of
space travelers. 1 MS is a physiological phenomenon as
well as a pathophysiological disorder, which can result
in serious of symptoms, including nausea and vomiting.
MS not only has major influence on travel activities, but
also is a common medical cause of permanent grounding
of pilots and student pilots as it interferes with their per⁃
formance in the air and flight safety.2 Unfortunately,
there are few effective interventions in treating MS. 3
MS is the responses of central nervous system to unfa⁃
miliar motion stimulation transmitted to the vestibular
nuclei, archicerebellum, other brainstem structures, au⁃
tonomic centers and hypothalmus.4 However, the under⁃
lying neurochemical and neuropharmacological mecha⁃
nisms and signalling pathways of MS are not completely
understood. 3 Some studies indicate that neurotransmit⁃
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ters, such as acetylcholine, noradrenaline and hista⁃
mine, play important roles in the development of MS. 5, 6
It is believed that histaminergic neuron system in cen⁃
tral nerve system is involved in the development of the
symptoms and signs of MS. Antihistamine drugs block
histaminergic inputs to nervous system via H1 receptors
（H1R）to prevent MS. 6· In the present study, we stud⁃
ied the expression of H1R in the vestibular nucleus and
the influences of motion stimulation and anti-MS drug
promethazine（an antihistamine drug）on the H1R ex⁃
pression in rats. We also investigated the role of H1R in
vestibular nucleus in the development of MS and its un⁃
derlying signal transduction.
Materials & methods
Animals and treatments
Healthy Sprague-Dawley rats（12 males and 12 fe⁃
males, 200 g－250 g）were used in this study. The rats
were randomly divided into four groups（6 rats in each）
depending on the treatment:（1）MS(-)/Drug(-)—no mo⁃
tion stimulation or anti-MS drug treatment（the control
group）;（2）MS( + )/Drug(-)—motion stimulation with
no anti-MS drug treatment;（3）MS(-)/Drug(+ )—an⁃
ti-MS drug（promethazine, 0.25 mg, i.p）only with no
motion stimulation; and（4）MS(+)/Drug(+)—prometha⁃
zine treatment at 30 minutes before motion stimulation.
Motion stimulation
MS was induced by complex rotation motion stimula⁃
tion.７ Before exposure to motion stimulation, rats were
allowed to move freely in the cage in the experimental
device. To induce MS, the device was rotated clockwise
at an acceleration of 20°/s2 up to a maximum speed of
120°/s, followed by similar rotation in the reversed direc⁃
tion, and the rotation continued for 60 minutes. Two rats
were tested at same time. Conditioned taste aversion was
used as a behavioral indicator of MS, i.e. measurement
of the intake volume of 0.15% sodium saccharin solu⁃
tion（SS）within 45 minutes after motion stimulation.８
Paired student’s t test was used（CHISS software）in da⁃
ta analysis, and P＜0.05 was considered of statistical
significance.
Immunofluorescence staining of H1 receptors
Under anesthesis with 10% chloralhydrate, the rat
was perfused through the left ventricle with phosphate
buffered saline（PBS）, followed by a ice-cold fixative
containing 4% paraformaldehyde in 0.1 M PBS（pH
7.4）. The rat was then decapitated and the brianstems
removed and immersed in 4% paraformaldehyde in 0.1
M PBS for 2 hours, followed by dehydration with 15%
and 30% sucrose solutions. Cryostat sections（thick⁃
ness, 10 μm）were prepared at the level of vestibular nu⁃
cleus. The sections were treated with 5% normal sheep
serum diluted in PBS（pH 7.4）for 30 minutes to de⁃
crease nonspecific background staining. After rinsing
with PBS, the sections were incubated with rabbit poly⁃
clonal IgG against H1R（Santa Cruz）at dilution of 1∶
50 for 24 hours, followed by triple washes with PBS con⁃
taing 0.2% Triton X-100, 10 minutes each. This was
followed by incubation with goat anti-rabbit IgG with
FITC（Invintrogen）at dilution of 1∶200 for 60 minutes
at room temperature. After another round of triple wash⁃
es, the sections were mounted for immunofluorescence
microscopic examination for H1R in the vestibular nu⁃
cleus. Control sections were treated similarly except that
the anti-H1R antibodies were replaced by rabbit serum.
Western blot analysis
Harvest of brainstem was similar as described above.
The brainstem tissue at the vestibular nucleus level was
collected and kept at -80℃ before western blot tests.
Cryostat brianstem specimens were lysed with a buffer
containing 0.1% SDS, 1% igepal CA-630, 0.5% sodium
deoxycholate, 0.01% phenylmethylsulfonyl fluoride, 3%
aprotinin and 1 mM sodium orthovanadate for 30 min⁃
utes. Identical amounts of protein lysates were dissolved
by 12% SDS-PAGE, followed by electroblot analysis on⁃
to a nitrocellulose membrane（Invitrogen）. After triple
rinsing with Tris buffle（20 minutes each）, the mem⁃
brane was blocked with 5% milk PBS for 30 minutes
and then probed with rabbit anti-H1R primary antibody
（1∶1000）（Santa Cruz） for 24 hours. The membrane
was then triple washed and incubated with goat anti-rab⁃
bit secondary antibody（IgG）with horseradish peroxi⁃
dase（HRP） at 1∶3000 dilution（Beijing Zhongshan
Goldenbridge Biotechnology Co.）for 1 hour. Immunob⁃
lots were detected by an enhanced chemiluminescence
（ECL） detection system（Amersham Pharmacia Bio⁃
tech）. β-actin expression was used as control.
Results
Motion stimulation induced the conditioned taste
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aversion
As showed in Table 1, the mean SS intake volume of
the MS(+)/Drug(-) group（8.8 ml）was significantly less
than that of the MS(-)/Drug(-) group（15.1 ml）（P <
0.01）, indicating successful induction of conditioned
taste aversion apparently in response to motion stimula⁃
tion. The mean SS intake volume of the MS(-)/Drug(+ )
group（14.8 ml）was similar to that of the MS(-)/Drug
(-) group, showing that 0.25 mg promethazine had little
effect on SS intake in the rat. The mean SS intake vol⁃
ume of MS(+)/Drug(+) group（9.6 ml）was greater than
that of the MS(+)/Drug(-) group（P < 0.01）, but less than
that of the MS(-)/Drug(-) or MS (-) /Drug (+) group（P<
0.01）, indicating that the conditioned taste aversion
（MS）induced by motion stimulation was inhibited par⁃
tially by anti-MS drug promethazine.
Motion stimulation increased H1R expression in the
vestibular nuclueus
Immunofluorescence staining showed positive expres⁃
sion of H1R in the vestibular nucleus（Figure 1a）,
which was enhanced by motion stimulation（Figure 1b）
but not significantly affected by promethazine, with（Fig⁃
ure 1d）or withou exposure to motion stimulation（Fig⁃
ure 1c）.
Figure 1 Immunofluorescent staining of H1R in the vestibular nucleus. (a) Positive staining of H1R in an animal without motion
stimulation or anti-MS drug（promethazine）. (b) Staining in an animal who has received motion stimulation but no promethazine
showing significantly enhanced staining of H1R compared with (a). (c) Staining in an animal with promethazine treatment but no
motion stimulation showing immunofluorescent staining similar to (a), indicating little effects by promethazine on H1R expression. (d)
Staining in an animal who received promethazine (0.25 mg) before motion stimulation showing immunofluorescent staining similar to
(b), indicating that increased H1R expression by motion stimulation is not inhibited significantly by promethazine. × 400.
Group
MS(-)/Drug(-)
MS(+)/Drug(-)
MS(-)/Drug(+)
MS(+)/Drug(+)
F value
P value
n
6
6
6
6
Sodium saccharin solution intake
15.1 ± 0.4
8.8 ± 0.3*
14.8 ± 0.6△
9.6 ± 0.3*△#
346.82
<0.01
Table 1 Sodium saccharin solution intake by rats
（ml, Mean ± S.D）
*Compared with the MS(-)/Drug(-) control group，P < 0.01；△Compared
with the MS(+ )/Drug(-) group，P < 0.01；# Compared with the MS(-)/
Drug (+) group，P < 0.01. MS: motion stimulation; Drug: promethazine
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Western blot analysis also showed expresseion of
H1R protein at the vestibular nucleus level（Figure 2,
Line 1）, which was not significantly affected by pro⁃
methazine treatment（Figure 2, Line 3）. Motion stimula⁃
tion increased expression of H1R protein（Figure 2,
Line 2）, which was not significantly inhibited by pro⁃
methazine（Figure 2, Line 4）.
Discussion
MS is considered a response of nervous system to mo⁃
tion stimulation, involving various nervous structures in⁃
cluding the vestibular system, vomiting center, brain
stem network, cerebellum, hypothalamus as well as the
autonomic nervous system.4, 9 Motion stimulation is de⁃
tected by vestibular hair cells that are located in the ves⁃
tibular end organs of the inner ears. Under motion stimu⁃
lation, vestibular hair cells in the semicircular canal and
otolith receptors are activated. The hair cells in the oto⁃
lith receptors are sensitive to linear acceleration. Angu⁃
lar accelerations stimulate the hair cells in the semicir⁃
cular canals. Vestibular afferent signals from the hair
cells in the semicircular canal and otolith receptors are
transmitted to the neurons in vestibular nuclei in the
brainstem, in turn to other structures in brain. Vestibu⁃
lar information also projects to autonomic nuclei, raising
vestibulo-autonomic responses. In addition to direct in⁃
puts from vestibular afferents, the vestibular nuclei re⁃
ceive substantial projections from cortical, cerebellar,
and other brain stem structures. These structures pro⁃
vide the vestibular nuclei with numerous extra-vestibu⁃
lar cues. The vestibular nucleus plays a key role in ves⁃
tibular information signaling.
The neurochemical and neuropharmacological mecha⁃
nisms of MS have been studied extensively, but the un⁃
derlying mechanisms and signaling pathways are not
completely understood. Some experimental and clinical
studies indicate that neurotransmitters, such as acetyl⁃
choline, noradrenaline and histamine, play important
roles in the development of MS. 10, 6 It is believed that
histamine and its receptors in central nerve system are
involved in the development of the symptoms of MS, in⁃
cluding emesis. 6
Histamine is distributed extensively, but unevenly,
throughout the brain. 11 Histamine is a multifunctional
messenger that acts mainly as a neurotransmitter or neu⁃
romodulator in the brain. The role of histamine as a neu⁃
rotransmitter was finally established in 1980s.11,12. Immu⁃
nohistochemistry studies have shown that there are hista⁃
minergic neurons in the brains of rats, which are concen⁃
trated in the hypothalamus-autonomic nervous system.
13 The vestibular nuclei have, like other brain stem struc⁃
tures, histamine fiber innervation. 14 However, the exact
roles of histamine and histamine-containing neurons in
these areas in MS are not clear. Some experimental and
Figure 2 Western blot analysis of H1R expression in brainstem tissues at vestibular nucleus level. Control rats without motion
stimulation (MS) or anti-MS drug treatment showed positive expression of H1R in brainstem tissue at vestibular nucleus level (Line
1). Motion stimulation enhanced the expression（Line 2）. Promethazine had no significant influence on H1R expression regardless of
motion stimulation (Line 4 and Line 3). β-actin was used as loading control. The membrane is representative of two repeated
experiments.
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clinical studies indicate that vestibular functions are reg⁃
ulated directly or indirectly by the histaminergic nerve
system. Histamine has been shown to modulate the
hair-cell-afferent synaptic transmission, acting both at
the pre- and the post synaptic terminals. 15 There is
study evidence indicating that histamine acts as a hair
cell transmitter in frog semicircular canal. 16 A report
showed that histamine levels in the hypothalamus and
pons-medulla oblongate increased significantly follow⁃
ing MS in rats and the increase was suppressed after the
rats were given a-fluoromethylhistadine, an irreversible
inhibitor of histamine-forming enzyme (a histadine de⁃
carboxylase).17 These findings indicate an important role
of histamine in MS.
The effects of histamine as a neurotransmitter or neu⁃
romodulator result from its binding to specific histamine
receptors. Up to now at least four subtypes of histamine
receptors, including H1, H2, H3 and H4 receptors, have
been found. 18 Recently the expressions and locations of
histamine receptors in inner ear have been identified.
Studies have showed expressions of H1, H2, and H3 re⁃
ceptor proteins and mRNAs in rat cochleae. 19 Immuno⁃
histochemical studies have showed that H1, H2, and H3
receptors exist in rabbit endolymphatic sac. 20 H1 recep⁃
tors have also been found in the semicircular canal sen⁃
sory epithelia of frog and mouse. 21 These findings sug⁃
gest that histamine receptors have a central role in func⁃
tions of the inner ear including peripheral vestibular or⁃
gans. Of the four types of histamine receptors, H1R is re⁃
lated more closely to MS. H1R can be found in the hypo⁃
thalamus, nucleus tractus solitarius, dorsal motor nucle⁃
us of vagus nucleus, nucleus ambiguous, lateral vestibu⁃
lar nucleus, and emetic center. 22, 23 It is believed that
H1Rs are involved in the development of MS symptoms
including emesis. 6，17
In the present study, both immunofluorescence stain⁃
ing and western blot analysis showed expression of H1R
that was enhanced by motion stimulation. Our findings
again indicate that H1Rs in the vestibular nucleus are
associated with MS.
Anti-histamine drugs (H1R blockers) are commonly
used in the treatment of vertigo and MS, althogu their ac⁃
tion sites and underpinning mechanisms remain poorly
defined. 21 The sites of action for these drugs are thought
to include the vestibular receptors, vestibular nuclei,
cerebellum, reticular area and vomiting center. 24
Promethazine, an H1R blocker, can effectively pre⁃
vent MS.24 In the present study, conditioned taste aver⁃
sion（representing presence of MS）induced by motion
stimulation was partially inhibited by promethazine at a
dose of 0.25 mg, although promethazine did not signifi⁃
cantly affect MS-stimulated expressions of H1R in the
vestibular nuclei. This is probably due to that prometha⁃
zine plays its anti-MS role by competing the binding
sites on H1R with histamine rather than by inhibiting
the expression of H1R in the vestibular nuclei.
Mechanisms of MS are yet to be completely under⁃
stood and effective interventions for prevention of MS
are yet to be developed. 3 We hope that the present study
helps to understand the neuropharmacological mecha⁃
nisms and signalling pathways of MS, and facilitate de⁃
velopment of treatments to prevent MS in the future.
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